Deferred Income Tax Expense (Benefit) of Oncology Institute, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Oncology Institute, Inc. annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Oncology Institute, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $0.
  • Oncology Institute, Inc. annual Deferred Income Tax Expense (Benefit) for 2025 was $32,000.
  • Oncology Institute, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $0.
  • Oncology Institute, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $76,000, a 71% increase from 2022.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)

Oncology Institute, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $32,000 -$32,000 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $0 +$76,000 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $76,000 +$187,000 +71% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $263,000 +$979,000 +79% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $1,242,000 +$102,000 +7.6% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $1,344,000 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY

Oncology Institute, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 +$26,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q1 2023 $26,000 -$206,000 -114% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $180,000 -$41,000 -19% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $221,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.